Brand Name
Zelsuvmi
Generic Name
Berdazimer
View Brand Information FDA approval date: April 04, 2025
Form: Kit
What is Zelsuvmi (Berdazimer)?
ZELSUVMI™ is indicated for the topical treatment of molluscum contagiosum in adults and pediatric patients 1 year of age and older. ZELSUVMI™ is a nitric oxide releasing agent indicated for the topical treatment of molluscum contagiosum in adults and pediatric patients 1 year of age and older.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment